Respiratory, Infectious Disease and Oncology
The Respiratory, Infectious Disease and Oncology (RIO) Clinical Trials Team conducts clinical trials of new drugs for patients with respiratory conditions such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD), as well as respiratory infectious disease and lung cancer. The team also run clinical trials of new vaccines in healthy volunteers.
Teton 2 - New IPF Treatment
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with IPF
Trial status:
Active, not recruiting
Contact:
RIO Clinical Trials Unit
Whistle-PF a new oral treatment for patients with Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis (IPF) or non-IPF Progressive Pulmonary Fibrosis (PPF)
Trial status:
Recruiting
Contact:
Maddy Simson